A Bayesian hierarchical push-forward method for cluster Randomized Controlled Trial power calculations in complex humanitarian settings
This paper introduces a Bayesian hierarchical push-forward method that integrates prior information on cluster and individual dropout to improve power calculations and trial design for cluster-randomized controlled trials in complex humanitarian settings, demonstrated through a forthcoming study in Bangladesh and a publicly available R Shiny application.
Original paper licensed under CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the chaotic aftermath of a humanitarian crisis, where displaced families move unpredictably and resources are scarce, designing a medical study is an exercise in navigating the unknown. Researchers often turn to cluster randomized trials, a method where entire groups of people, such as villages or refugee camps, are assigned to receive a new health intervention or a standard one. This approach is vital for testing treatments in places where individual tracking is impossible, but it carries a unique risk: entire groups can vanish from the study due to conflict, displacement, or safety concerns. When these groups disappear, the data becomes incomplete, and the study may lose the ability to detect whether a treatment actually works. To solve this, scientists must move beyond simple guesses about how many people will stay in the study and instead embrace a framework that treats uncertainty not as a flaw, but as a central part of the calculation.
A team of statisticians and public health experts has developed a new way to plan these difficult studies, one that acknowledges that the future is rarely a single, fixed point. Instead of calculating a single number for how likely a study is to succeed, they created a method that generates a full range of possibilities, showing how the odds of success shift as conditions change. Their work was driven by an upcoming trial in Cox's Bazar, Bangladesh, which aims to help refugees from Myanmar manage heart disease and hepatitis C. In this setting, the researchers knew that people might leave the study area or that entire camps might become inaccessible, making traditional planning methods unreliable. By using a Bayesian approach, which allows them to weave in what is already known from past studies while explicitly modeling the chaos of the present, they built a tool that predicts the strength of a trial under many different scenarios of loss and disruption.
The researchers began by looking at a similar trial recently completed in Myanmar, where they analyzed how many people stayed in the study and how the loss of participants was distributed across different villages. They found that sometimes people left individually, but other times, entire villages were lost to follow-up due to conflict. They used this real-world data to build a mathematical model that simulates thousands of potential versions of the upcoming Bangladesh trial. In each simulation, they varied the number of clusters, the size of the groups, and the rate at which people might drop out, including scenarios where whole clusters disappear. This process, which they call a "push-forward" method, takes the uncertainty about how many people will remain and pushes it through the study design to see what the final results might look like.
The results of their simulations revealed a critical flaw in the way studies are often planned. Traditional methods usually provide a single number, such as an 80 percent chance of success, which can give a false sense of security. The new method showed that even when the average chance of success looks good, there is often a significant risk that the actual power of the study could fall much lower. For instance, in some scenarios, while the average power looked sufficient, there was still a thirty-five percent chance that the study would be too weak to detect a real effect. This happens because the loss of entire groups creates a different kind of uncertainty than losing individuals one by one. The researchers found that simply increasing the number of people in each group does not always fix the problem; sometimes, adding more clusters is far more effective at ensuring the study can withstand the loss of a few villages.
When they applied this new framework to the Bangladesh trial, using data from the Myanmar study to inform their predictions, the results were reassuring but nuanced. They tested six different scenarios for how people might leave the study, ranging from random individual departures to the loss of multiple entire clusters. In every scenario, the median chance of the study succeeding remained high, often above 87 percent. However, the method also highlighted that in the worst-case scenario, where several clusters were lost, there was still a 35 percent chance the study would fall short of the standard 80 percent power threshold. This level of detail allows researchers to make more informed decisions, understanding not just if a study will likely work, but how vulnerable it is to the specific types of disruption common in humanitarian crises.
To make this complex tool accessible to other scientists and public health workers, the team built a free, interactive software application that anyone can use to design their own trials. This tool allows investigators to input their own assumptions about how many people might leave and see a visual representation of the risks and rewards of different study sizes. By shifting the conversation from a single point estimate to a range of possibilities, this work helps researchers design studies that are robust enough to survive the unpredictability of crisis zones. It offers a way to plan with eyes wide open, acknowledging that in humanitarian settings, the only certainty is that things will change, and that a good study design must be flexible enough to account for that reality.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.